Situation: A 24-year-old woman with type 1 diabetes mellitus uses insulin glargine at bedtime and insulin lispro with meals. Her written plan calls for 1 unit of lispro for every 10 g of carbohydrate in a meal, plus a correction of 1 unit for every 50 mg/dL (2.8 mmol/L) that her premeal glucose is above 150 mg/dL (8.3 mmol/L). Later, her log shows this pattern on most nights for 1 week: Bedtime: 142 mg/dL (7.9 mmol/L) 03:00: 54 mg/dL (3.0 mmol/L) 07:00: 246 mg/dL (13.7 mmol/L) She wakes with headaches and damp sheets. Which change in her plan should the nurse anticipate?

A low glucose around 03:00 followed by a high fasting glucose, with night sweats and morning headache, fits the Somogyi effect: nighttime hypoglycemia triggers counterregulatory hormones that cause a rebound high. It is treated by reducing the evening basal dose or adding a bedtime snack. The dawn phenomenon, by contrast, shows a morning rise without a nighttime low.

The pattern described here is a classic presentation of rebound hyperglycemia following nocturnal hypoglycemia. The sequence of a bedtime glucose of 142 mg/dL (7.9 mmol/L), a 03:00 glucose of 54 mg/dL (3.0 mmol/L), and a 07:00 glucose of 246 mg/dL (13.7 mmol/L) shows a clear drop into hypoglycemia during the night, followed by a marked rise by morning. The associated symptoms of headache on waking and damp sheets from night sweats are consistent with a hypoglycemic episode during sleep. The most likely explanation is the Somogyi effect, in which nocturnal hypoglycemia triggers the release of counterregulatory hormones such as glucagon, epinephrine, cortisol, and growth hormone, leading to a rebound elevation in blood glucose by morning.

The key clinical distinction is between the Somogyi effect and the dawn phenomenon. Both can produce morning hyperglycemia, but the underlying mechanism and management differ. In the Somogyi effect, the morning high is preceded by a documented nighttime low, whereas in the dawn phenomenon, glucose rises in the early morning hours without a preceding hypoglycemic episode. Watch out! The presence of a 03:00 glucose of 54 mg/dL (3.0 mmol/L) is the critical finding that points to the Somogyi effect rather than the dawn phenomenon.

Feature	Somogyi effect	Dawn phenomenon
Nighttime glucose pattern	Hypoglycemia (e.g., 02:00–04:00) followed by rebound hyperglycemia	Progressive rise in glucose during early morning without preceding low
Mechanism	Counterregulatory hormone response to hypoglycemia	Nocturnal growth hormone and cortisol surge increasing insulin resistance
Typical symptoms	Night sweats, morning headache, restless sleep	Often asymptomatic
Primary management	Reduce evening basal insulin or add bedtime snack	Increase evening basal insulin or adjust timing of basal dose

The management of the Somogyi effect focuses on preventing the nocturnal hypoglycemic episode. Reducing the bedtime dose of insulin glargine is the appropriate intervention because it lowers the amount of basal insulin acting during the night, thereby reducing the risk of hypoglycemia at 03:00. Once the nighttime low is prevented, the counterregulatory hormone surge does not occur, and the morning glucose should normalize. An alternative approach in some patients is to add a bedtime snack to provide carbohydrate during the night, but in this scenario, the patient’s bedtime glucose is already 142 mg/dL (7.9 mmol/L), which is not low enough to suggest that a snack alone would be sufficient. The primary problem is excessive basal insulin action overnight.

The other options do not address the underlying mechanism. Raising the dinner lispro dose would increase insulin action in the evening and could worsen the nocturnal hypoglycemia. Adding a small lispro dose at 03:00 would be inappropriate because the patient is already hypoglycemic at that time; administering rapid-acting insulin would be dangerous. Taking more lispro with breakfast would only treat the morning hyperglycemia without preventing the nighttime low that causes it, and it would not address the recurrent pattern.

The evidence base regarding the Somogyi effect has been debated. Some studies using continuous glucose monitoring have questioned how frequently rebound hyperglycemia actually occurs after nocturnal hypoglycemia. Key point! In clinical practice, the Somogyi effect is considered uncommon, and many episodes of morning hyperglycemia are due to the dawn phenomenon or insufficient basal insulin. However, when a documented nighttime low is followed by a morning high, the Somogyi effect remains a recognized explanation, and the standard teaching is to reduce the overnight basal insulin dose. The 1980 study by Gale and colleagues demonstrated that rebound hyperglycemia can occur after untreated nocturnal hypoglycemia, with fasting glucose values exceeding 7 mmol/L (126 mg/dL) in a subset of patients. More recent studies have found that post-hypoglycemic nocturnal hyperglycemia does occur in some individuals with type 1 diabetes, although it is not universal. The clinical approach remains to confirm the pattern with glucose monitoring and then adjust the basal insulin downward when the Somogyi effect is identified.